Revolutionising Drug Discovery with Single Cell Analysis & AI

We utilise AI and machine learning technology to fast-track the discovery of novel cancer therapies.

Pioneering AI for
Cancer Research

We are pushing the boundaries of AI and machine learning to tackle key challenges in cancer drug discovery.

Our platform analyses tumour heterogeneity at the single cell level to identify and target resistant cancer cell subpopulations.

We apply advanced machine learning methods to understand and overcome cancer drug resistance mechanisms.

Our AI platform analyses vast biological datasets to uncover novel drug targets and mechanisms of drug resistance

Using Single Cell Analysis, we analyze Primary Patient cells to capture tumour hetrogeneity

We analyse tumour mutations and drug resistance pathways to identify novel avenues for targeted cancer therapy